Insider Transactions in Q1 2023 at Cyclacel Pharmaceuticals, Inc. (CYCC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Paul Mc Barron Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,200
+49.77%
|
-
|
|
Jan 31
2023
|
Mark Kirschbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,200
+50.0%
|
-
|
|
Jan 31
2023
|
Spiro George Rombotis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,600
+47.92%
|
-
|